Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochemical Journal

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BJ20021532PMID 12585964PMCID PMC1223391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo

  2001cited by this paper
• Regulatory Mechanisms Controlling Human Hepatocyte Nuclear Factor 4α Gene Expression

  2001cited by this paper
• Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids.

  2001cited by this paper
• Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis

  2001cited by this paper
• FXR, a bile acid receptor and biological sensor.

  2000cited by this paper
• Role of Smad Proteins and Transcription Factor Sp1 in p21Waf1/Cip1 Regulation by Transforming Growth Factor-β*

  2000cited by this paper
• Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor*

  2000cited by this paper
• A Hormone Response Element in the Human Apolipoprotein CIII (ApoCIII) Enhancer Is Essential for Intestinal Expression of the ApoA-I and ApoCIII Genes and Contributes to the Hepatic Expression of the Two Linked Genes in Transgenic Mice*

  2000cited by this paper
• Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

  2000cited by this paper
• Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.

  2000cited by this paper
• Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha.

  2000cited by this paper
• Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene

  1999cited by this paper
• Identification of a nuclear receptor for bile acids.

  1999cited by this paper
• Bile acids: natural ligands for an orphan nuclear receptor.

  1999cited by this paper
• Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors.

  1999cited by this paper
• Transactivation of the Human Apolipoprotein CII Promoter by Orphan and Ligand-dependent Nuclear Receptors

  1998cited by this paper
• A Short Proximal Promoter and the Distal Hepatic Control Region-1 (HCR-1) Contribute to the Liver Specificity of the Human Apolipoprotein C-II Gene

  1998cited by this paper
• Two Hepatic Enhancers, HCR.1 and HCR.2, Coordinate the Liver Expression of the Entire Human Apolipoprotein E/C-I/C-IV/C-II Gene Cluster*

  1997cited by this paper
• A single nucleotide substitution in the promoter region of the apolipoprotein C-II gene identified in individuals with chylomicronemia.

  1996cited by this paper
• In Vivo Footprinting Analysis of the Hepatic Control Region of the Human Apolipoprotein E/C-I/C-IV/C-II Gene Locus*

  1996cited by this paper
• Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus.

  1995cited by this paper
• The RXR heterodimers and orphan receptors.

  1995cited by this paper
• Evolutionary Duplication of a Hepatic Control Region in the Human Apolipoprotein E Gene Locus

  1995cited by this paper
• A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice.

  1993cited by this paper
• Orphan receptor HNF-4 and liver-specific gene expression.

  1993cited by this paper
• Genetic mutations affecting human lipoproteins, their receptors, and their enzymes.

  1993cited by this paper
• Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3.

  1992cited by this paper
• Organization of the regulatory elements and nuclear activities participating in the transcription of the human apolipoprotein B gene.

  1992cited by this paper
• Organization of the regulatory elements and nuclear activities participating in the transcription of the human apolipoprotein B gene.

  1992cited by this paper
• Bile acid biosynthesis.

  1992cited by this paper
• Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice.

  1991cited by this paper
• Transcriptional regulation of the human apolipoprotein genes.

  1991cited by this paper
• Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis.

  1990cited by this paper
• Apolipoprotein gene expression in the rabbit: abundance, size, and distribution of apolipoprotein mRNA species in different tissues.

  1988cited by this paper
• Structure of apolipoprotein C-IIToronto, a nonfunctional human apolipoprotein.

  1987cited by this paper
• Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (APOC1, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI.

  1986cited by this paper
• Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages.

  1985cited by this paper
• Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements.

  1985cited by this paper
• The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence, and identification of 5' homologous sequences among apolipoprotein genes.

  1985cited by this paper
• Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

  1982cited by this paper
• Lipolytic enzymes and plasma lipoprotein metabolism.

  1980cited by this paper
• Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat.

  1979cited by this paper
• Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.

  1978cited by this paper
• Primary structure of very low density apolipoprotein C-II of human plasma.

  1977cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper
• Activation of lipoprotein lipase by apolipoprotein glutamic acid. Formation of a stable surface film.

  1973cited by this paper

• The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease

  2021cites this paper
• Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease

  2021cites this paper
• Bile acids and their receptors in metabolic disorders.

  2021cites this paper
• Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.

  2017cites this paper
• Farnesoid-X Receptor (FXR) as a Promising Pharmaceutical Target in Atherosclerosis.

  2017cites this paper
• Bile acids and their receptors.

  2017cites this paper
• The interrelationship between bile acid and vitamin A homeostasis.

  2017cites this paper
• Bile acid nuclear receptor FXR and digestive system diseases

  2015cites this paper
• Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression

  2014cites this paper
• The role of vitamin A in bile acid synthesis and transport and the relevance for cholestatic liver disease

  2013cites this paper
• A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.

  2012cites this paper
• Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma

  2012cites this paper
• STAT1 Interacts with RXRα to Upregulate ApoCII Gene Expression in Macrophages

  2012cites this paper
• proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells

  2011cites this paper
• The Fox and the Rabbits—Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease

  2011cites this paper
• Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC)-based Quantitative Proteomics Study of a Thyroid Hormone-regulated Secretome in Human Hepatoma Cells*

  2011cites this paper
• Bile acid-activated receptors in the treatment of dyslipidemia and related disorders.

  2010cites this paper
• Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment.

  2010cites this paper
• FXR an emerging therapeutic target for the treatment of atherosclerosis

  2009cites this paper
• Comparative study of bile acid composition of bile of the European vendace Coregonus albula L. and the European whitefish Coregonus lavaretus L. under conditions of technogenic water reservoir pollution

  2007cites this paper
• Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter Published, JLR Papers in Press, April 7, 2006.

  2006cites this paper
• The Farnesoid X Receptor A Molecular Link Between Bile Acid and Lipid and Glucose Metabolism

  2005cites this paper
• The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.

  2005cites this paper
• Atvb in Focus Novel Approaches to the Treatment of Dyslipidemia the Farnesoid X Receptor a Molecular Link between Bile Acid and Lipid and Glucose Metabolism

  year unknowncites this paper